Joel Slade
Novartis (United States) · 36 works · 642 citations · h-index 14
Top works
- Separation of diastereomers using a low cost preparative medium-pressure liquid chromatograph
- Asymmetric addition of organometallics to chiral ketooxazolines. Preparation of enantiomerically enriched .alpha.-hydroxy acids
- Angiotensin converting enzyme inhibitors: 1,5-benzothiazepine derivatives
- Resolution of .alpha.-substituted mandelic acids via chiral oxazolines using pressurized chromatography
- Selective deprotection of alkyl t-butyldimethylsilyl ethers in the presence of aryl t-butyldimethylsilyl ethers with bismuth bromide
- Bis-β,β′-conjugate addition
- In-situ generation of Et3SiBr from BiBr3 and Et3SiH and its use in preparation of dialkyl ethers
- Synthesis of(±)-descarboxylquadrone
- A Convenient Synthesis and Resolution of R- and S- Atrolactic Acid in High Enantiomeric Purity
- Etherification of alkoxydialkylsilanes with carbonyl compounds
- New Trends in Palladium‐Catalyzed Transfer Hydrogenations Using Formic Acid
- Chemoselective deprotection of tertiary benzylamines and reduction of carbon–carbon double bonds in the presence of benzyl and benzyloxymethyl ethers
- A Concise Synthesis of a Novel Insulin-Like Growth Factor I Receptor (IGF-IR) Inhibitor
- A Scalable Zinc Activation Procedure Using DIBAL-H in a Reformatsky Reaction
- ChemInform Abstract: A CONVENIENT SYNTHESIS AND RESOLUTION OF R‐ AND S‐ATROLACTIC ACID IN HIGH ENANTIOMERIC PURITY
- A Practical Enantioselective Synthesis of a Novel Peptide Deformylase Inhibitor
- Optimization and Scale-Up of the Grandberg Synthesis of 2-Methyltryptamine
- A Practical Synthesis of the Dual Matrix Metalloprotease/Tumor Necrosis Factor Inhibitor MMP090
- A new synthesis of the orally active renin inhibitor aliskiren
- ChemInform Abstract: RESOLUTION OF α‐SUBSTITUTED MANDELIC ACIDS VIA CHIRAL OXAZOLINES USING PRESSURIZED CHROMATOGRAPHY